Submit Manuscripts
Author Information
Subscribe/Renew
Email Alerts
Feedback
RSS Feed

About the Journal
Editorial Board & Staff

Interventions Homepage Imaging Homepage Interventions Homepage Imaging Homepage

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions

ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2007; 49:1265-1271, doi:10.1016/j.jacc.2007.02.021
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v49,p1902)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adriaenssens, T.
Right arrow Articles by Schömig, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adriaenssens, T.
Right arrow Articles by Schömig, A.

Does Addition of Estradiol Improve the Efficacy of a Rapamycin-Eluting Stent?

Results of the ISAR-PEACE Randomized Trial

Tom Adriaenssens, MD, Julinda Mehilli, MD*, Rainer Wessely, MD, Gjin Ndrepepa, MD, Melchior Seyfarth, MD, Anna Wieczorek, Birgit Blaich, PhD, Raisuke Iijima, MD, Jürgen Pache, MD, Adnan Kastrati, MD1 and Albert Schömig, MD2

Deutsches Herzzentrum, Technische Universtität, Munich, Germany.


Figure 1
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1 Release Kinetics of Rapamycin From the ERES and RES

Kinetics are displayed as cumulative release of rapamycin over time in percent of total rapamycin on the stents (± SD). ERES = estradiol plus rapamycin-eluting stent; RES = rapamycin-eluting stent.

 

Figure 2
View larger version (30K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 2 Flow Chart of Study Participants

 

Figure 3
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 3 Cumulative Frequency Curves of In-Stent Late Lumen Loss at Follow-Up Angiography for the 2 DES Groups

DES = drug-eluting stent; other abbreviations as in Figure 1.

 

Figure 4
View larger version (38K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 4 Incidences of Angiographic and Clinical Restenosis for the ERES and RES Groups

TLR = target lesion revascularization; other abbreviations as in Figure 1.

 

Figure 5
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 5 Probability of Survival Free of MI for the ERES Group and for the RES Group

MI = myocardial infarction; other abbreviations as in Figure 1.

 
 
  cardiology careers collections past issues search home